Study demonstrates potential for improving access
New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities
How to screen for and manage treatment-triggered uveitis
In search of optimal imaging biomarkers, best methods for long-term follow-up
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Growing public interest in hallucinogens highlights their therapeutic promise and potential perils
Research indicates strong rationale for expanding trial eligibility criteria
A three-step plan aimed at strengthening the institute’s infrastructure includes a renewed focus on mentorship
A study of the procedure’s efficacy is cause for reflection, not rejection
Traditional enrollment methods for clinical research are often manual, time-consuming and expensive, so shifting to an electronic process can accelerate recruitment while reducing costs.
Emerging treatment option for patients with advanced disease
Advertisement
Advertisement